Maynard E. Hamrick

481 total citations
18 papers, 408 citations indexed

About

Maynard E. Hamrick is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Cell Biology. According to data from OpenAlex, Maynard E. Hamrick has authored 18 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Cell Biology. Recurrent topics in Maynard E. Hamrick's work include Pharmacogenetics and Drug Metabolism (4 papers), Hormonal and reproductive studies (4 papers) and Hormonal Regulation and Hypertension (3 papers). Maynard E. Hamrick is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Hormonal and reproductive studies (4 papers) and Hormonal Regulation and Hypertension (3 papers). Maynard E. Hamrick collaborates with scholars based in United States. Maynard E. Hamrick's co-authors include Barry R. Stripp, James R. Gillette, Nicola Zampaglione, David J. Jollow, J.R. Mitchell, Kennon Francis, Raymond H. Menard, J R Gillette, Thomas N. Riley and Jane Millen and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Maynard E. Hamrick

18 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maynard E. Hamrick United States 9 262 110 78 77 57 18 408
Donald C. Davis United States 9 277 1.1× 110 1.0× 47 0.6× 100 1.3× 47 0.8× 16 482
Sidney S. Levin United States 6 276 1.1× 252 2.3× 63 0.8× 105 1.4× 77 1.4× 15 538
G. Seidel Germany 9 283 1.1× 162 1.5× 31 0.4× 101 1.3× 62 1.1× 40 566
Koichi SUGENO Japan 9 256 1.0× 169 1.5× 30 0.4× 105 1.4× 49 0.9× 33 523
Sten V. Jakobsson Sweden 8 234 0.9× 198 1.8× 34 0.4× 94 1.2× 103 1.8× 9 466
Parke Dv United Kingdom 6 221 0.8× 132 1.2× 23 0.3× 76 1.0× 74 1.3× 17 474
David J. Porubek United States 12 201 0.8× 178 1.6× 64 0.8× 87 1.1× 25 0.4× 18 507
A. Klutch United States 10 201 0.8× 119 1.1× 106 1.4× 37 0.5× 49 0.9× 13 439
Robert Grundin Sweden 13 207 0.8× 132 1.2× 34 0.4× 71 0.9× 66 1.2× 18 444
Kin-ichi ONODA Japan 11 235 0.9× 104 0.9× 95 1.2× 72 0.9× 55 1.0× 25 364

Countries citing papers authored by Maynard E. Hamrick

Since Specialization
Citations

This map shows the geographic impact of Maynard E. Hamrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maynard E. Hamrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maynard E. Hamrick more than expected).

Fields of papers citing papers by Maynard E. Hamrick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maynard E. Hamrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maynard E. Hamrick. The network helps show where Maynard E. Hamrick may publish in the future.

Co-authorship network of co-authors of Maynard E. Hamrick

This figure shows the co-authorship network connecting the top 25 collaborators of Maynard E. Hamrick. A scholar is included among the top collaborators of Maynard E. Hamrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maynard E. Hamrick. Maynard E. Hamrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ravis, William R., et al.. (1992). Effect of a Perfluorochemical Emulsion on the Rat Hepatic Mixed Function Oxidase System. Journal of Pharmacy and Pharmacology. 44(3). 219–223. 3 indexed citations
2.
Hamrick, Maynard E., et al.. (1988). Inhibition of acetaminophen hepatotoxicity by chlorpromazine in fed and fasted mice. Biochemical Pharmacology. 37(12). 2467–2471. 21 indexed citations
3.
Millen, Jane, Thomas N. Riley, I. W. Waters, & Maynard E. Hamrick. (1985). ChemInform Abstract: 2‐(β‐ARYLETHYLAMINO)‐ AND 4‐(β‐ARYLETHYLAMINO)QUINAZOLINES AS PHOSPHODIESTERASE INHIBITORS. Chemischer Informationsdienst. 16(21). 1 indexed citations
4.
Millen, Jane, Thomas N. Riley, I. W. Waters, & Maynard E. Hamrick. (1985). 2-(.beta.-Arylethylamino)- and 4-(.beta.-arylethylamino)quinazolines as phosphodiesterase inhibitors. Journal of Medicinal Chemistry. 28(1). 12–17. 8 indexed citations
5.
Francis, Kennon & Maynard E. Hamrick. (1984). Exercise and Uric Acid: Implication in Cardiovascular Disease. Journal of Orthopaedic and Sports Physical Therapy. 6(1). 34–38. 13 indexed citations
6.
Francis, Kennon & Maynard E. Hamrick. (1980). Effects of dantrolene on adrenal cortical function. Biochemical Pharmacology. 29(12). 1669–1672. 5 indexed citations
7.
Hamrick, Maynard E., et al.. (1977). Interaction of spironolactone and digoxin in dogs.. Journal of Pharmacology and Experimental Therapeutics. 202(3). 696–701. 8 indexed citations
8.
Hamrick, Maynard E., et al.. (1976). Rapid TLC Determination of Methadyl Acetate and Some In Vitro Metabolites. Journal of Pharmaceutical Sciences. 65(1). 137–138. 3 indexed citations
9.
Hamrick, Maynard E., et al.. (1974). Stoichiometry of drug metabolism in maturing male rats. Biochemical Pharmacology. 23(16). 2325–2327. 4 indexed citations
10.
Hamrick, Maynard E., Nicola Zampaglione, Barry R. Stripp, & James R. Gillette. (1973). Investigation of the effects of methyltestosterone, cortisone and spironolactone on the hepatic microsomal mixed function oxidase system in male and female rats. Biochemical Pharmacology. 22(3). 293–310. 43 indexed citations
11.
Zampaglione, Nicola, David J. Jollow, J.R. Mitchell, et al.. (1973). ROLE OF DETOXIFYING ENZYMES IN BROMOBENZENE-INDUCED LIVER NECROSIS. Journal of Pharmacology and Experimental Therapeutics. 187(1). 218–227. 174 indexed citations
12.
Stripp, Barry R., Raymond H. Menard, Nicola Zampaglione, Maynard E. Hamrick, & J R Gillette. (1973). EFFECT OF STEROIDS ON DRUG METABOLISM IN MALE AND FEMALE RATS. Drug Metabolism and Disposition. 1(1). 216–223. 20 indexed citations
13.
Stripp, Barry R., Maynard E. Hamrick, & James R. Gillette. (1972). Effect of 3-methylcholanthrene induction on the carbon tetrachloride-induced changes in rat hepatic microsomal enzyme system. Biochemical Pharmacology. 21(5). 745–747. 28 indexed citations
14.
Stripp, Barry R., Nicola Zampaglione, Maynard E. Hamrick, & James R. Gillette. (1972). An Approach Measurement of the Stoichiometric Relationship between Hepatic Microsomal Drug Metabolism and the Oxidation of Reduced Nicotinamide Adenine Dinucleotide Phosphate. Molecular Pharmacology. 8(2). 189–196. 11 indexed citations
15.
Stripp, Barry R., Maynard E. Hamrick, Nicola Zampaglione, & James R. Gillette. (1971). THE EFFECT OF SPIRONOLACTONE ON DRUG METABOLISM BY HEPATIC MICROSOMES. Journal of Pharmacology and Experimental Therapeutics. 176(3). 766–771. 59 indexed citations
16.
Gillette, James R., Barry R. Stripp, Nicola Zampaglione, Maynard E. Hamrick, & Hènry A. Sasame. (1971). Studies of the stoichiometric relationships between the oxidation of drugs and the oxidation of reduced pyridine nucleotides by liver microsomal enzymes. Chemico-Biological Interactions. 3(4). 266–267. 1 indexed citations
17.
Hamrick, Maynard E., et al.. (1968). The Effect of Digoxin on Rat Contractile Proteins. Pharmacology. 1(5). 303–311. 3 indexed citations
18.
Hamrick, Maynard E. & Paul J. Fritz. (1966). Enzymatic adaptation: Molecular basis for cardiac glycoside action?. Biochemical and Biophysical Research Communications. 22(5). 540–546. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026